Modification of a novel angiogenic peptide, AG30, for the development of novel therapeutic agents

We previously identified a novel angiogenic peptide, AG30, with antibacterial effects that could serve as a foundation molecule for the design of wound-healing drugs. Toward clinical application, in this study we have developed a modified version of the AG30 peptide characterized by improved antibac...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakagami, Hironori, Nishikawa, Tomoyuki, Tamura, Nao, Maeda, Akito, Hibino, Hajime, Mochizuki, Masayoshi, Shimosato, Takashi, Moriya, Toshinori, Morishita, Ryuichi, Tamai, Katsuto, Tomono, Kazunori, Kaneda, Yasufumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823230/
https://www.ncbi.nlm.nih.gov/pubmed/21812915
http://dx.doi.org/10.1111/j.1582-4934.2011.01406.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823230/
https://www.ncbi.nlm.nih.gov/pubmed/21812915
http://dx.doi.org/10.1111/j.1582-4934.2011.01406.x

Ejemplares similares